Meet-the-Professor Session:
195. When to Switch Antiretroviral Therapies
Saturday, October 29, 2016: 7:00 AM-8:15 AM
Room: 288-290

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • understand current recommendations for when to switch antiretroviral treatment of patients with HIV
  • identify key factors to consider in selecting an alternative antiretroviral regimen for patients with HIV

Target Audience: Fellows, HIV clinicians, HIV specialists, Infectious diseases physicians, Members-in-training, Public health practitioners

Tracks: Adult ID, HIV-STD-TB

Moderator:  Pablo Tebas, MD, FIDSA, University of Pennsylvania

7:00 AM
David Alain Wohl, MD

7:20 AM
Roger Bedimo, MD

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours .125 of pharmacy CE

ACPE Number: 0221-9999-16-279-L02-P


P. Tebas, Merck: Consultant , Consulting fee
Glaxo: Adjudication Committe member , Consulting fee

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.